Lixte Biotech Hlds
(LIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,728 | -4,699 | -3,460 | -1,727 | -3,265 |
| Accounts payable and accrued liabilities | 36 | 25 | -28 | -41 | 47 |
| Other Working Capital | -13 | -162 | -115 | 45 | -118 |
| Other Operating Activity | 2,563 | 1,840 | 1,535 | 697 | 1,205 |
| Operating Cash Flow | $-4,143 | $-2,996 | $-2,068 | $-1,026 | $-2,131 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,908 | 3,908 | 3,808 | 3,707 | 4,602 |
| Other Financing Activity | -11 | -21 | -11 | -11 | 0 |
| Financing Cash Flow | $3,897 | $3,887 | $3,797 | $3,696 | $4,602 |
| Beginning Cash Position | 5,069 | 5,069 | 5,069 | 5,069 | 2,599 |
| End Cash Position | 4,824 | 5,961 | 6,799 | 7,739 | 5,069 |
| Net Cash Flow | $-246 | $891 | $1,729 | $2,670 | $2,470 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,143 | -2,996 | -2,068 | -1,026 | -2,131 |
| Free Cash Flow | -4,143 | -2,996 | -2,068 | -1,026 | -2,131 |